Research programme: ZAP 70 protein tyrosine kinase modulators - X-37
Latest Information Update: 28 Dec 2023
Price :
$50 *
At a glance
- Originator X-37
- Class Small molecules
- Mechanism of Action ZAP 70 protein tyrosine kinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Autoimmune disorders
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Dec 2023 No recent reports of development identified for research development in Autoimmune-disorders in USA
- 28 Nov 2019 ZAP 70 protein tyrosine kinase modulators - X-37 is available for licensing as of 14 Nov 2019. https://x37.ai/
- 14 Nov 2019 Early research in Autoimmune disorders in USA (unspecified route) before November 2019